Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection

Product News   Jun 12, 2013

 
Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Owlstone Medical, Cancer Research UK Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

Product News

Owlstone Medical and Cancer Research UK begin trial to improve the speed of detection and diagnosis of multiple cancer types.

READ MORE

Gyros Protein Technologies Introduces New ADA Solution for Immunogenicity Market

Product News

Gyros Protein Technologies launches a new version of its anti-drug antibody solution for the immunogenicity market.

READ MORE

Arcinova Use FlowSyn for Efficient Scale-Up of Challenging Batch Processes

Product News

Arcinova has invested in a FlowSyn™ continuous flow reactor enabling them to develop and simplify the scale-up of a challenging API batch process.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE